Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Open, randomised, crossover study assessing the effects of Lisdexamfetamine dimesylate on cytochrome P450 substrate pharmacokinetics in Volunteers.

Trial Profile

Open, randomised, crossover study assessing the effects of Lisdexamfetamine dimesylate on cytochrome P450 substrate pharmacokinetics in Volunteers.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jun 2015

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Lisdexamfetamine (Primary) ; Caffeine; Dextromethorphan; Midazolam; Omeprazole
  • Indications Attention-deficit hyperactivity disorder
  • Focus Pharmacokinetics
  • Sponsors Shire
  • Most Recent Events

    • 17 Dec 2014 New trial record
Restricted Access

If your organization has a subscription then there are several options available to help you access AdisInsight while working remotely. Contact us at AsktheExpert.AdisInsight@springer.com to find out more.
Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top